| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Chirayu Ramanbhai Amin CEO | XNSE Exchange | Y0R76F109 CUSIP |
| India Country | 14,858 Employees | 29 Jul 2026 Last Dividend | - Last Split | - IPO Date |
Alembic Pharmaceuticals Limited is a renowned entity in the pharmaceutical sector, engaged in the development, manufacturing, and marketing of a broad spectrum of pharmaceutical products both within India and internationally. With its inception dating back to 1907, the company has established a significant presence and is headquartered in Vadodara, India. Alembic Pharmaceuticals Limited boasts a diverse portfolio that includes branded specialty medicines, generic formulations, and active pharmaceutical ingredients, catering to a multitude of therapeutic areas. Additionally, the company has an extensive export operation, making its products available on a global scale.
Alembic Pharmaceuticals Limited offers an array of branded specialty medicines tailored to meet specific therapeutic needs. These medicines span across various therapeutic areas, including cardiology, gynecology, gastrology, ophthalmology, dermatology, nephrology/urology, orthopedics, anti-infective, cold and cough, veterinary, and anti-diabetic, among others. This comprehensive range is designed to address the complex health requirements of patients through effective and specialized treatment options.
The company manufactures generics formulations in oral solids, oncology oral solids and injectables, general injectables, ophthalmic products, dermatology, and oral suspension categories. These generic formulations are made to match the quality standards of their branded counterparts, providing cost-effective treatment solutions across various medical conditions. Their wide-reaching generics portfolio ensures accessibility and affordability of essential medications to a broader patient population.
Alembic Pharmaceuticals is also a prominent producer of Active Pharmaceutical Ingredients (APIs), supplying the raw materials required for drug manufacturing. These APIs cover a broad spectrum of therapeutic categories, supporting both the company's internal product development and the needs of other pharmaceutical manufacturers worldwide. By producing high-quality APIs, Alembic plays a critical role in the global pharmaceutical supply chain, ensuring the availability of essential medications.